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ABSTRACT 
A disconnect exists between innovations and the adoption of such 
innovations, specifically within healthcare facilities. This 
disconnect results in various healthcare challenges — ones that 
could be addressed by successfully adopting and integrating an 
innovation into organisational processes — not being addressed. To 
address the challenge of innovation adoption within healthcare, it 
is proposed that a tool be developed to identify areas that should 
be addressed to improve the chances of the successful adoption and 
integration of innovations into existing systems in a public 
healthcare facility. By assessing a facility’s readiness for innovation 
adoption, it is possible to identify the barriers to the successful 
adoption of innovations. Knowing what such challenges or barriers 
to innovation adoption are will allow role players to address these 
challenges or barriers. The purpose of this paper is to develop the 
healthcare innovation adoption readiness assessment tool (HIARAT), 
which measures the maturity of a healthcare facility’s innovation 
adoption process. The HIARAT was validated through a face 
validation workshop, and through a case study at a South African 
public healthcare facility. 
OPSOMMING 
'n Ontkoppeling bestaan tussen innovasies en die aanneming van 
sulke innovasies, spesifiek binne gesondheidsorgfasiliteite. Hierdie 
ontkoppeling lei tot verskillende gesondheidsorguitdagings wat tans 
nie aangespreek word nie, maar wat aangespreek behoort te kan 
word deur die suksesvolle aanneming en integrasie van 'n innovasie 
in organisatoriese prosesse. Om die uitdaging van innovasie-
aanneming binne gesondheidsorg aan te spreek, word voorgestel dat 
'n instrument ontwikkel word om gebiede te identifiseer wat 
aangespreek moet word om die kanse van die suksesvolle aanneming 
en integrasie van innovasies in bestaande stelsels in 'n openbare 
gesondheidsorgfasiliteit te verbeter. Deur die beoordeling van 'n 
fasiliteit se gereedheid vir innovasie aanneming, is dit moontlik om 
die struikelblokke tot die suksesvolle aanneming van innovasies te 
identifiseer. Om te weet wat sulke uitdagings of hindernisse vir die 
aanneming van innovasies is, sal rolspelers in staat stel om hierdie 
uitdagings of hindernisse aan te spreek. Die doel van hierdie artikel  
is om die gesondheidsorg-innovasie-aannemingsgereedskap-
assesserings-instrument (HIARAT) te ontwikkel, wat die 
volwassenheid van 'n gesondheidsorgfasiliteit se aannemingsproses 
meet. Die HIARAT is gevalideer deur middel van 'n gesigs-evaluasie 
werkswinkel, en deur middel van 'n gevallestudie by 'n Suid-
Afrikaanse openbare gesondheidsorgfasiliteit.
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1 INTRODUCTION 
Healthcare in South Africa faces many challenges, and is in need of major improvements [1]. These 
challenges include the quality of care being provided, health inequities (public healthcare versus 
private healthcare), rising costs, an ageing population, and managerial and operational weaknesses 
[2]. Nonetheless, South Africa has made significant progress in healthcare since 1994, including 
legislative and policy frameworks that allow for a single integrated health system [2], an essential 
drugs programme, free primary healthcare, and a better immunisation programme [3].  
 
Globally, and in South Africa, there have been significant advances in healthcare research and 
technologies over the past few years, and large amounts of money have been allocated to research 
and development in the industry. In the 2015/16 financial year, the South African government spent 
R 11.3 billion on research and development across all sectors, 18.1 per cent of which was spent on 
healthcare-related research and development [4]. 
 
However, innovative solutions developed to improve aspects of healthcare frequently are not 
implemented at the facilities where they are needed [5]. The literature suggests that the adoption 
of these solutions in practice is hindered by a number of challenges. A need thus exists to evaluate 
the healthcare system, and more specifically healthcare facilities, with the aim of identifying the 
barriers and limitations to innovative solution adoption. Such an evaluation will allow healthcare 
managers to address the factors that hinder the successful adoption and integration of innovative 
solutions at their facilities, ensuring that the system is conducive to the adoption of innovations. 
The development of an ‘innovation readiness’ assessment tool will contribute towards more 
effectively achieving such assessments. 
 
The research objectives that supported the aim of this investigation were:  
 
1. To review the literature addressing the healthcare landscape in South Africa, current strategies 
for managing innovation, and innovative solution adoption in the South African healthcare 
environment.  
2. To develop an assessment tool that can be used in healthcare facilities to assess their readiness 
for innovation adoption.  
3. To test and validate the feasibility of the developed tool by performing a field trial at a public 
healthcare facility.  
2 HEALTHCARE IN SOUTH AFRICA 
South Africa has made innovative medical advances due to state-funded health research; some 
notable achievements include the first human heart transplant and computed tomography [6]. 
However, since the start of the 1980s there has been a restructuring of state expenditure in the 
healthcare system. In 1994 specifically, the emphasis of South Africa’s public healthcare services 
shifted towards the aim of increasing affordability and improving accessibility. This shift was 
accompanied by an increase in government spending on public healthcare [7], with the focus being 
placed on primary healthcare and “healthcare for all” [7]. Unfortunately, this has also meant a 
stagnation in the amount of state-funded health research [6]. 
 
Despite the apparent trade-off between innovation, increasing affordability, and improving 
accessibility, innovation remains a leading force in attaining the goal of minimising healthcare costs 
while maximising quality [8]. To innovate successfully, health research funding is necessary, in 
conjunction with effectively adopting healthcare innovations into appropriate sections of the 
national healthcare system.  
 
Organisations tend to find the adoption of innovations difficult; the reasons for this range from the 
potential risks involved, to a lack of resources to carry out innovations [9]. Barriers to the adoption 
of innovations can be grouped into the characteristics of the organisation, the characteristics of the 
actual innovation, and the characteristics of the environment [10].  
 149 
3 INNOVATION 
Innovation is centred on processes and principles that are necessary for an invention to be developed 
into an innovation that will then be practically implemented [9]. Multiple different innovation 
adoption processes have been described by authors. These include the processes proposed by Rogers 
[11], Van Zyl [12], Hoffman [13], Kim [14], Ehigie and McAndrew [15], and Tidd and Bessant [10]. In 
order to choose an innovation process to use during the development of the HIARAT, the number of 
citations and the date of publication for each author’s innovation process were considered. The top 
two most cited processes were proposed by Rogers [11] and Tidd and Bessant [10]1. Of these two 
processes, Tidd and Bessant [10] were published in 2009, whereas Rogers [11] was published in 2003. 
Tidd and Bessant’s [10] model was considered to cover the innovation adoption process effectively; 
and, because it had the second highest number of citations and was published more recently, the 
decision was made to use this innovation adoption model during the development of the HIARAT. 
However, it should be noted that this innovation adoption process element of the HIARAT can be 
changed or updated for future versions of the HIARAT, if deemed necessary for the tool’s 
improvement. 
 
Tidd and Bessant’s [10] model of the innovation adoption process (Figure 1) shows the innovation 
adoption process from an organisation’s perspective, looking to incorporate innovative 
opportunities. (These innovations can come from internal or external sources.)  
 
 
Figure 1: Process model of the innovation adoption processes within an organisation [10] 
The first phase of the innovation process model (search) consists of finding areas in the 
organisation’s environment where there is potential for change [10]. When managing the adoption 
process of an innovation in an organisation, the trigger or source of the innovation should be 
considered [10]. Triggers of innovation will influence the first phase of the innovation process model. 
Triggers of innovation can be influenced by multiple factors, including new markets, technologies, 
political rules, and public opinion [10].  
 
Phase two (select) consists of the organisation weighing the risks and rewards to determine which 
innovations to pursue [10]. The third phase (implement) involves the organisation making the 
innovation a reality at its facility [10]. The goal of the innovation process is to derive some form of 
value from these innovations. The final phase (capture) entails encapsulating value from the 
innovation and, if the innovation fails, the reasons for failure [10]. The result of any process is the 
collective outcomes of participants or role players at each level [16]. 
                                                     
1  This was determined by considering the number of citations Rogers [11], Van Zyl [12], Hoffman [13], Kim 
[14], Ehigie & McAndrew [15] and Tidd & Bessant [10] each had on Google Scholar for the papers in which 
they described the innovation process (refer to the list of references for the papers that were considered) 
at the time of writing this article. 
Innovation Process
Innovative strategyInnovative organisation Value Capture
 
Select: 
What are we going to do and 
why?
Implement:
How are we going to make it 
happen?
Capture:
How are we going 
to get the benefits 
from the 
innovation?
Search:
How can we find 
opportunities for 
innovation?
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3.1 Role players in the innovation process 
Essentially, innovation is about people [9]. Rothwell [17] identified having certain key individuals 
present as a characteristic of successful innovation. The central role players in an organisation’s 
innovation process can be identified as the following: 
 
i. The networker, who studies trends within technology, society, markets, and regulations to 
recognise opportunities. The networker is also responsible for creating connections with 
external organisations, or with individuals who have corresponding objectives [18]. The 
networker is also known as the technological gatekeeper [17]. The networker is active in Phase 
1 — the search phase; 
ii. The co-ordinator, who ensures that projects’ resources, objectives, and risks are balanced; 
and will promote concepts and opportunities. The co-ordinator must schedule, prioritise, and 
guarantee project completion through overcoming the obstacles that are faced [18]. The co-
ordinator will be active in Phases 2, 3, and 4 — the selection, implementation, and capture 
phases; 
iii. The builder, who creates, demonstrates, and defines tangible concepts; the builder will ensure 
that the product or service is ready to be supplied to the customer [18]. The builder will be 
active during Phase 3 — the implementation phase; 
iv. The anthropologist, who must have an understanding of people’s interactions (both emotional 
and physical) with services, products, their environment, and with other people. The 
anthropologist can anticipate stakeholders’ needs and is able to influence people’s attitudes 
and behaviours [18]. The anthropologist will be active during Phases 2 and 3 — the selection 
and implementation phases; 
v. The product champion [17] or leader, who ensures that the organisation’s activities are 
aligned with its objectives and strategies. The leader will prioritise opportunities to implement 
and will monitor a project’s metrics [18]. This person is committed to the implementation of 
the innovation, and is able to push the project through the internal barriers [17]. The product 
champion will be active during phases 2, 3, and 4 — the selection, implementation, and 
capturing phases. 
3.2 Measuring innovation  
The innovation performance of organisations has been extensively studied [19], because 
organisations recognise the value of innovations. However, the majority of metrics that have been 
studied tend to be for an organisation looking to incorporate innovation into its culture and develop 
innovative ideas, rather than to measure its ability to adopt an innovation (regardless of the source 
of the innovation). Hagedoorn and Cloodt [19] identified four indicators that are used to measure 
an organisation’s innovative performance: research and development inputs, patent citations, 
patent counts, and new product announcements. From Hagedoorn and Cloodt’s indicators, it can be 
speculated that the term ‘innovative performance’ refers to an organisation’s ability to develop 
innovative concepts and ideas, but not necessarily its performance when adopting innovations. The 
innovation capability maturity model, which is based on the capability maturity model [18], can be 
useful in measuring an organisation’s innovation ability throughout the stages of the innovation 
lifecycle. It is not limited to the measurement of an organisation’s ability to produce innovative 
ideas or an innovative culture. 
 
A capability maturity model (CMM) is a technique that determines how mature an organisation is, 
by comparing the organisation’s processes and the methods used in these processes against 
structured levels that represent how reliably an organisation can sustain the desired outcomes [20]. 
A CMM allows an organisation to understand their current position in comparison with the best 
practices in a specific domain (e.g., innovation); the capability maturity gives the organisation an 
indication of what direction it should go in to improve its outcomes in a specific domain [20]. A 
maturity model shows what needs to be improved, but does not show how the improvement should 
take place [21]. The model helps an organisation set improvement priorities and objectives [21]. 
CMMs are used across many different industries, and for many different applications [20]. Despite 
the large number of domains where the maturity model has been applied, the objectives and 
structures of the models remain very similar [22] [20]. Maturity models are often used to aid the 
improvement of complex systems or concepts [22]. 
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The levels that are used in maturity models define an evolutionary pathway to an ideal process at 
the highest maturity level [21]. CMMs tend to have the same five levels [20], which, as described by 
the capability maturity model integration, are [23]: 
 
Level 1: Initial (ad-hoc): in this level, the process is unpredictable and badly controlled; 
Level 2: Managed: in this level, processes are characterised for specific projects; 
Level 3: Defined (standard): in this level, processes are characterised for the organisation; 
Level 4: Quantitative (measured): In this level, processes are measured; 
Level 5: Optimising: in this level, there is a focus on improvement. 
When assigning an organisation to a level, it must have met the requirements of each of the previous 
levels [20]. The CMM has been an inspiration and the basis for the development of many other 
maturity models that have been developed for application in different settings and domains, 
including the development of the innovation capability maturity model (ICMM) [24]. 
3.3 Innovation in healthcare 
Healthcare innovation is defined as the introduction and adoption “of a new concept, idea, service, 
process, or product aimed at improving treatment, diagnosis, education, outreach, prevention and 
research, and with the long-term goals of improving quality, safety, outcomes, efficiency and costs” 
[8]. Healthcare innovations target healthcare processes (the methods used for the production of 
goods or for delivery of a service), products (the goods or services that the customer pays for), or 
structures (business models affecting the internal and external organisation structure) [8].  
 
In spite of substantial improvements made within the healthcare industry, there are still many 
inefficiencies [25]. There is no longer a problem with a lack of innovative evidence-based medical 
practices; the issue is that not enough of these medical innovations are successfully adopted in 
health facilities [5]. Even if the case for an improvement is clear, strategies that will translate the 
innovative solutions into practice have not been effective, properly implemented, or used. The goal 
is not where the point of confusion lies; the path for achieving the goal is the challenge [26]. 
 
Multiple implementation theories have been published in an attempt to support effective innovation 
implementations. Healthcare researchers have begun to recognise the importance of 
implementation science [27]. Damschroder et al. [27] have compared many of these healthcare 
innovation adoption theories, and have revealed that considerable overlap exists; but they state 
that each theory misses one or more critical constructs. Damschroder et al. [27] thus created the 
‘consolidated framework for implementation research’ (CFIR) by consolidating the common building 
blocks from the various other published theories. For the purpose of this investigation, the CFIR will 
be analysed further, assuming that it successfully encompasses the necessary building blocks of a 
healthcare implementation framework (because Damschroder et al. [27] have successfully 
consolidated the critical aspects from the existing adoption theories). Other innovation models and 
frameworks that have been found during the literature analysis tend only to be applicable to creating 
an innovative environment within the healthcare facility, and not to dealing with innovation 
adoption. 
4 METHODOLOGY 
The tool selected on which to base the HIARAT was the capability maturity model (CMM). The CMM 
most directly correlated with the aim of assessing a facility’s current state of readiness to adopt an 
innovation. The CMM enables the organisation being assessed to carry out an improvement process 
once the barriers to the innovation adoption process have been identified by the tool2 [24]. The 
HIARAT should be a standardised approach that can be used at any healthcare facility to identify 
the facility’s barriers to innovation adoption; thereafter the healthcare facility can, of its own 
accord, carry out an improvement process suited to its challenges, needs, and resources.  
 
                                                     
2  The scope of this investigation is to develop a tool that assesses how ready a facility is for innovation 
adoption; the tool does not provide the organisation with an improvement process. The tool highlights 
areas that hinder innovation adoption, thus identifying areas in the organisation where resources should be 
focused to address the barriers identified by the tool. 
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In order to develop the HIARAT, the general tool development process proposed by Whiting et al. 
[28], and the more specific developmental process for a CMM proposed by De Bruin et al. [29], were 
combined, as shown in Figure 2. These are the steps that were followed to develop the HIARAT. 
 
During the preliminary conceptual phase, decisions on the scope of the tool and on the model’s 
architecture needed to be made. Thereafter the first draft of the tool was populated through item 
generation. Finally, the tool was subjected to testing, which included face validation and a field 
trial to refine the tool. 
 
Development Process of the Healthcare Innovation Adoption Assessment Tool
Preliminary Conceptual Decisions Populate Testing
 
Preliminary 
Conceptual 
Decisions
Item 
Generation
Face 
Validation
Refine 
Tool
Field Trials
Scope
Model 
Architecture
Rework 
required?
Rework 
required?
no
yes yes
no
First Draft 
of Tool
Finalised 
Tool
Respondents
Key Drivers
Intended 
Audience
Application 
Method
Extent of 
Tool
 
Figure 2: Combined tool development process followed to develop the HIARAT 
5 THE HEALTHCARE INNOVATION ADOPTION READINESS ASSESSMENT TOOL (HIARAT) 
The HIARAT is divided into two parts: i) the conceptual model that represents the organisation’s 
innovation adoption readiness — i.e., the innovation adoption capability maturity level of the 
facility, which is shown in Figure 3; and ii) the user interface, which is used to gather the necessary 
information from the facility being assessed in order for the process maturity capability levels for 
each of the domains to be determined. The user interface is shown in Appendix A. The results from 
the maturity analysis allow the facility to pinpoint the areas and factors of innovation adoption 
process that hinder the adoption of the innovation, for each of the domains. Once the barriers and 
limiting factors to successful adoption and integration of an innovation have been identified, the 
relevant role-players can proceed to identify actions that would address these barriers and 
limitations to the successful adoption and integration of an innovation. The tool thus acts as a 
decision support system; it does not focus on proposing any improvement initiatives, but rather on 
the identification of barriers and challenges to the adoption of innovation. 
5.1 Conceptual tool 
The conceptual tool consists of three planes, as seen in Figure 3. The innovation adoption process 
axis versus the domains axis provides a description of the innovation adoption process of a specific 
organisation (Table 1). The maturity capability levels axis versus the domains axis provides specific 
maturity capability statements for each domain (Table 2).  
 
The statements in the description matrix (Table 1) and in the specific domain maturity capability 
matrix (Table 2) are both used to create the user interface — the process maturity capability matrix 
in Figure 3. There are five domain-specific process maturity sections in this matrix that have to be 
filled in to determine the maturity levels. In order for the assessor3 to complete the specific domain 
process maturity capability matrices, information needs to be obtained from the healthcare facility 
whose innovation adoption readiness is being assessed. Once the information is obtained from the 
facility, these matrices can be used to determine the innovation adoption readiness of the 
organisation in each step of the innovation process and within each domain.  
                                                     
3  The assessor is an external body, such as a qualified industrial engineer or project manager, who assesses 
the readiness for innovation adoption within that facility. 
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Thereafter the descriptions of the innovation adoption process for a specific domain were compared 
with the same domain’s maturity capability level statements; Table 3 to Table 7 were then 
developed, showing the process maturity capability for each of the five domains, which are referred 
to as the user interfaces of the HIARAT.  
 
 
Figure 3: Conceptual framework of the HIARAT (see online version for colour) 
5.1.1 Dimension 1: Capability maturity levels 
There needs to be a way to measure the innovation adoption readiness of a healthcare facility. The 
general maturity levels, described by CMM and ICMM, provide an effective and descriptive way of 
measuring how ready the domains (which are necessary to support the innovation adoption process) 
are, seeing that it is difficult to measure analytically how ‘innovation ready’ an organisation is. 
5.1.2 Dimension 2: Innovation adoption process 
By including the innovation adoption process dimension in the HIARAT, the tool becomes more 
thorough in describing a healthcare facility’s readiness to adopt an innovation. This is because the 
process dimension allows the organisation to determine what the barriers to innovation adoption 
are, but also in which phases of the innovation adoption process the barriers are. The innovation 
adoption process of an organisation is made up of five stages, as described by Tidd and Bessant [10]. 
5.1.3 Dimension 3: Domains 
There are numerous variables that influence the item generation in the domain section (shown as 
‘Domains’ in Figure 3). A domain describes a distinctive subset [30], which in this case is used to 
refer to a distinctive subset of the variables that affect (enable or hinder) the innovation adoption 
process.  
 
In order to divide the domain items into sections4, the consolidated framework for implementation 
research (CFIR) was considered. This framework discusses five constructs that are critical to the 
innovation adoption process: the intervention characteristics, the outer setting, the inner setting, 
the characteristics of individuals, and the process reference [27]. The subsections of the barriers 
and enabling factors of innovation adoption, as described by Tidd and Bessant [10], were considered; 
these subsections are environmental characteristics, organisational characteristics, and 
characteristics of the innovation. Lastly, Van Dyk’s [24] approach to determining the domains for 
the telemedicine service maturity model was considered. This approach was to consider the generic 
descriptions of the 5Ms of manufacturing (man, machine, method, material, and money) and align 
these with the telemedicine service [24].  
 
                                                     
4  These sections are necessary to divide the barriers and enabling variables into logical segments so that the 
assessment tool is more user-friendly; the capability maturity of the different domains during the 
innovation adoption process will vary, and this requires segmentation. 
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To divide the domains into sections, each of the 5Ms was considered and matched to the factors 
from the CFIR and the innovation adoption barriers. In summary, ‘machine’ aligns with the 
characteristics of the innovation, ‘man’ aligns with the characteristics of individuals, ‘method’ 
corresponds with the inner organisational setting, ‘material’ aligns with information acquisition, and 
‘cost’ aligns with the financial aspects of the innovation, the organisation, and the outer setting. 
Thus, within the HIARAT, there are five domain sections:  
 
i. The innovation’s characteristics: This domain refers to the characteristics of the innovation(s) 
that are being considered for adoption and integration into the organisation. The maturity of 
the specific innovation’s characteristics being adopted into an organisation will be measured.  
ii. Users: This domain includes the stakeholders that are directly involved in the innovation 
adoption process, as well as stakeholders of the innovation (certain stakeholders will be role 
players in the adoption process)5. Different role players are active during each phase of the 
innovation adoption process. The presence of specific users, and those users having an 
influence in the organisation, will influence the success of the innovation adoption process. 
iii. The organisational environment: This is a broad domain that encompasses some of the other 
domains (users domain and costs domain). However, in order not to condense this domain 
overly, the organisational environment will include the goals and objectives of the 
organisation, the culture, policies, and the organisation’s structure. 
iv. Information acquisition: This domain includes the factors of the external environment that 
affect the innovation adoption process, and the information acquisition and communication 
that happens within the organisation.  
v. Costs: This domain’s variables include all the financial aspects related to adopting an 
innovation during each phase of the innovation adoption process.  
5.2 User interfaces 
The HIARAT’s user interfaces work like a marking rubric; for each user interface, the characteristics 
— applicable to each of the four stages of the innovation adoption process — are marked against the 
maturity level that is most applicable to the facility.   
 
The first user interface, Table 3 in Appendix A, deals with determining the innovation adoption 
process maturity capability given a specific innovation’s characteristics. Seeing that this interface 
deals with a specific innovation, the assessor must determine whether the organisation has an 
innovation within one of the phases of the innovation adoption process. It is assumed that, if an 
innovation is in the adoption stage, for example, it would have gone through the preceding search 
and select phases. Within each stage of the innovation adoption process, there are characteristics 
of the innovation that have been identified, through the literature, that affect the innovation 
adoption process. These characteristics are measured against the five levels of maturity to 
determine the capability of the innovation — i.e., how well the innovation’s characteristics point to 
adoption within the organisation. Table 3 will thus help the organisation to determine whether the 
innovation is ready for adoption within the organisation, and/or what areas of the 
innovation/organisation need to be improved so that adoption will be a success. In the event that 
the organisation is not considering any innovation at the time of the assessment, this domain (Table 
3) will be skipped. 
 
The second user interface, the user domain, or Table 4 in Appendix A, deals with the people who 
are involved in the innovation adoption process. The users in this domain include the role-players 
who are directly involved in the innovation adoption process, and the stakeholders of the innovation 
(certain stakeholders will be role-players in the adoption process). The presence of specific users 
who have influence and control in the organisation will influence the success of the innovation 
adoption process. There are central innovation role-players within each stage of an organisation’s 
innovation adoption process. These users are measured against the five levels of maturity to 
determine the capability of the organisation’s users to facilitate and support the innovation adoption 
process. Table 4 thus helps the organisation to determine whether it has the necessary role-players 
in the organisation, and what areas need to be improved, from management support to the role 
players, and their roles, influence, and power to ensure a successful innovation adoption process.  
                                                     
5  Stakeholders are different from role players; role players will have a hands-on position during the adoption 
process, whereas stakeholders are interested parties who influence decisions but do not necessarily have a 
primary role in the adoption process. A stakeholder can be a role player, and vice-versa. 
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The third user interface, shown in Table 5 in Appendix A, deals with the organisational environment 
domain, where the innovation adoption process takes place. This interface includes the 
organisation’s goals and objectives, and its structure, culture, and policies. The characteristics of 
the organisational environment are measured against the five levels of maturity to determine the 
capability of the organisational environment to follow and facilitate the innovation adoption 
process. Table 5 helps the organisation to determine what factors need to be improved to increase 
the effectiveness of the innovation adoption process.  
 
The fourth user interface, Table 6 in Appendix A, deals with information acquisition throughout the 
innovation adoption process. The interface includes the organisation’s access to information, the 
competitive pressures, the external policies, customer needs and resources, and the internal and 
external communication network. The factors influencing the organisation’s information acquisition 
environment are, in turn, measured against the five levels of maturity to determine the capability 
of the organisation to acquire information during the innovation adoption process. Table 6 
helps the organisation to determine what factors need to be improved for information acquisition. 
 
The final user interface, Table 7 in Appendix A, considers all of the finances involved during each 
phase of the innovation adoption process. The factors influencing the organisation’s financial 
resources are measured against the five levels of maturity to determine the capability of the 
organisation to fund the stages of the innovation adoption process. Table 7 helps the organisation 
to determine which areas of the innovation adoption process need to be better funded. 
6 VALIDATION 
In order to validate the HIARAT, a face validation and a field trial were conducted (refer to Figure 
2). When testing the HIARAT through face validation, a workshop was held where two subject matter 
experts were consulted. After adjustments were made in accordance with the validation workshop, 
a field trial was carried out to test and adjust the HIARAT further, where necessary. The field trial 
was conducted at a public healthcare facility in the Western Cape, with the assistance of the 
healthcare facility’s manager. 
6.1 Face validation workshop 
To conduct the face validation, two subject matter experts were consulted, during two separate 
face validation workshops, to determine the applicability of the developed HIARAT to evaluate the 
innovation adoption readiness/maturity in public healthcare facilities. The developer of the HIARAT 
facilitated the face validation workshops; an information pack (which included the background on 
why the assessment tool was developed, the aim of the assessment tool, and the objective of the 
HIARAT) was sent to each subject matter expert before the face validation workshops. Each subject 
matter expert completed a questionnaire during the workshop. The main improvements suggested 
during the workshops were: 
 
i. To clarify who would be conducting the assessments; 
ii. To ensure that the user interface is self-explanatory (implying that footnotes, which include 
definitions and explanations, should be included in the user interface);  
iii. To decrease the tool’s complexity by adding the statements into the user interface rather than 
having a separate questionnaire. (questionnaires were used to fill in the user interface for the 
first draft of the HIARAT.)  
 
It should be noted that no major concerns or adjustments were suggested during the workshops; all 
suggestions made were deemed valuable and were incorporated into the revised HIARAT. It should 
also be noted that the scoring of the subject matter experts differed in a number of areas; however, 
even if one subject matter expert scored a certain dimension highly, and the other considered that 
dimension to be lacking in some areas, that specific dimension would still be addressed. All aspects 
of the HIARAT that were scored three or less (out of five) during the face validation workshops were 
addressed when creating the second draft of the HIARAT.  
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6.2 Field trial 
The second stage in testing the HIARAT was carried out as a field trial at a public healthcare facility 
in the Western Cape Province6. The field trial was conducted to evaluate the usability, consistency, 
and validity [28] of the HIARAT. During the field trial, the developer of the HIARAT acted in her 
capacity as industrial engineer–in-training, and facilitated the assessment process of the healthcare 
facility. During the field trial, the user interfaces were filled out (Error! Reference source not 
found. to Table 7) by discussing the relevant information with the healthcare facility’s manager. 
This manager is a medical doctor who also takes responsibility for the general management of the 
facility, and hence is also knowledgeable about the innovation adoption process at that facility.  
 
The first user interface describes the innovation adoption process maturity capability for the 
innovation characteristics domain, in which the facility manager considered an innovation that had 
already gone through the innovation adoption process: an electronic scripting system. This 
innovation was created in-house through the recognition of a need within the facility. This innovation 
scored high maturity levels (between levels 4 and 5), meaning that the characteristics of this 
innovation bode well for adoption within the healthcare facility.  
 
Table 3 effectively covered the aspects of an innovation that influence the innovation adoption 
process. 
 
The second user interface describes the innovation adoption process for the users’ domain, in which 
high maturity levels were scored; during each phase of the innovation adoption process, a level 4 
was scored. The meaning of the maturity levels is that there are appropriate users within the facility 
who ensure a successful innovation adoption process. It is recommended that the facility formalise 
the innovation roles and ensure that all employees are encouraged to participate in the innovation 
adoption process.  
 
Table 4 effectively covered the aspects of users that influence the innovation adoption process; 
however, the definition of the networker will be adjusted so that it is more suitable for a public 
healthcare facility. It was found that the search phase of the adoption process is mostly driven by 
chancing upon needs within the facility, and not by people actively searching for the innovation. 
This is due to the limited resources available at a public healthcare facility.  
 
The third user interface describes the innovation adoption process for the organisational 
environment domain; maturity levels of two to four were scored for the phases of the innovation 
adoption process for this domain. The range of maturity levels shows that there is room for 
improvement within the organisational environment domain. Ideally, the change-resistant culture 
within the facility should be addressed. The Western Cape Department of Health contributes to the 
barriers to the facility’s innovation adoption process, and the organisation that is considered in the 
tool would include this government department because all public healthcare facilities in the 
Western Cape have to adhere to the goals, objectives, and values of the government department. 
The hierarchical structure of the organisation (which includes the healthcare facility and the 
Department of Health) creates obstacles to the innovation adoption process; the goals and 
objectives of the organisation are not clearly communicated to all personnel. And although the 
organisation’s vision includes innovation, it is not actively encouraged. Error! Reference source not 
found. effectively covered the aspects of the organisational environment that influence the 
innovation adoption process, although there will be a slight change of wording for the descriptions 
of the search phase, and the organisation will be considered to include the government department, 
seeing that public healthcare facilities abide by its goals and objectives. 
 
The fourth user interface describes the innovation adoption process for the information acquisition 
domain; maturity levels of one to four were scored for the phases of the innovation adoption process. 
The range of maturity levels shows that there is room for improvement within the facility’s 
information acquisition domain. The information acquisition procedure should ideally be 
standardised, which would facilitate the information flow between personnel at different 
organisational levels, or from employees who are not clinical personnel but still work in the 
healthcare facility. In addition, it is proposed that project management policies be created and 
managed at the healthcare facility to improve the outcomes of the innovation adoption process, and 
to synchronise resources and activities optimally.  
                                                     
6  The public healthcare facility requested to remain anonymous in the written report.  
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Table 6 effectively covered the aspects of the information acquisition domain that influence the 
innovation adoption process. However, the phrase ‘competitive pressures’ in the select phase will 
be replaced with ‘benchmarking pressures’, as there are instinctive negative connotations to the 
first phrase, even with the definition that explains the meaning behind the phrase. 
 
The final user interface describes the innovation adoption process for the cost domain; maturity 
levels of one to two were scored for the phases of the innovation adoption process. This low range 
of maturity levels shows that there is room for improvement within the organisation’s cost structure. 
The solution is thought to lie with the Department of Health; the government needs to provide the 
necessary funding that will support the uptake and implementation of innovations.  
 
Table 7 effectively covered the aspects of the cost domain that influence the innovation adoption 
process. This table is necessary; however, in future developments, weightings will be considered, 
because even though costs are a factor that hinder or enable the innovation adoption process, they 
do not stop the innovation from progressing if the personnel involved are passionate about adopting 
it. 
From the field trial, the conclusion can be drawn that the HIARAT is understandable by an external 
stakeholder at a public healthcare facility, and is effective in assessing a healthcare facility’s 
innovation adoption readiness. This maturity model is used at the discretion of the assessor, so it 
could be partially biased, and it is thus suggested that training for assessors is provided to ensure as 
little bias as possible. The feedback received while conducting the field trial was considered to 
refine the HIARAT further; this refined HIARAT is presented in Appendix A. 
7 CONCLUSION 
This investigation was undertaken to develop a tool to evaluate a healthcare facility to identify 
barriers and limitations to innovation adoption; the HIARAT was developed from this. The outputs 
from applying the HIARAT support the healthcare organisation in addressing the barriers to the 
innovation adoption process by identifying the areas that currently act as barriers, or where 
challenges to innovation adoption exist. 
 
There is much room for further research and development of the HIARAT. These improvements and 
research areas fall outside the scope of this investigation. Seeing that the tool is assessing the 
innovation adoption readiness of a specific facility, it is envisaged that some sort of value, such as 
an innovation readiness score, could be beneficial to healthcare facilities. This value will allow the 
facility to see whether there is an improvement at the healthcare facility if the assessment is done 
more than once. In order to come up with a single innovation readiness score for a facility, each 
domain would have to be weighted according to the urgency of a domain or section within the 
innovation adoption process. The cost dimension for a public healthcare facility would be given a 
lower weighting than the other four domains, due to the nature of a public healthcare facility. 
 
The tool could be developed to become more self-explanatory, so that a manager at a healthcare 
facility could administer the tool without needing an external assessor and/or an industrial engineer 
to conduct the assessment. Methods to achieve this could be through an Excel model where options 
from a drop-down menu are selected, or through a free web-based application where healthcare 
facilities would be able to compare their innovation readiness scores with each other, creating a 
benchmarking system between healthcare facilities. 
 
The population phase of the tool development process could be re-visited to conduct the assessment 
extensively during this phase. The method suggested by De Bruin et al. [29] could be used; this 
entails the use of an electronic survey that includes quantitative measures for measuring the items 
in the model. Re-visiting the population phase would allow the model to grow and become more 
effective at assessing the innovation adoption readiness of a facility. Further research could be done 
to expand the reach of the model to include the assessment of private healthcare facilities. The 
HIARAT is specifically geared towards public healthcare facilities; but the factors that drive public 
and private healthcare innovations are different, and these factors would affect the HIARAT. 
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APPENDIX A 
1 Description of the innovation adoption process (combined with Table 2 to develop the user interface) 
Table 1: Description of the innovation adoption process using five domains 
 Innovation adoption process 
Search  
 
(Finding innovation 
opportunities; these can be 
internal or external) 
Select  
 
(Portfolio management; what 
innovations will be adopted) 
Adoption  
 
(Implementing the chosen 
innovation into the 
organisation) 
Capture  
 
(Process control and risk 
management; tracking the 
success of the innovation) 
D
o
m
a
in
s 
Innovation  
 
(This could refer to process, product, organisational 
innovation, etc.) 
Perceived advantage, evidence 
strength, design quality 
Compatibility, trial-ability, 
complexity 
Adaptability Observability, verifiability 
Users  
 
(Medical personnel, patients, healthcare organisation, 
research & development organisations, regulatory 
agencies)  
Networker 
Co-ordinator, anthropologist, 
product champion 
Co-ordinator, builder, 
anthropologist, product 
champion 
Co-ordinator, product champion 
Organisational environment 
 
(Inner environment: goals, structure, culture, policies) 
Organisation communication 
procedures, culture, learning 
climate 
Decision-making procedure, 
influenced by organisational 
structure and goals & objectives 
Implementation policies, change 
management 
Quality control and risk 
management 
Information acquiring  
 
(Outer environment & internal information network: 
information access, competitive pressures, external 
policies, customer needs and resources, 
communication network) 
External and internal 
communication channels, ease 
of information access 
Competitive pressures, external 
policies and incentives, 
customers’ needs & resources 
Innovation adoption 
management: project 
management, communication 
network 
Communication network: 
feedback systems, quality 
management 
Costs 
 
(Financial aspects of the innovation adoption process) 
Research and development 
budget 
Acquisition costs, financial 
incentives, financial resources, 
opportunity costs 
Adoption costs 
Operational and maintenance 
costs 
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2 Specific domain maturity capability (combined with Table 1 to develop the user interface) 
Table 2: Process capability maturity statements per level 
 
 
Maturity capability levels 
Level 0 Level 1 Level 2 Level 3 Level 4 Level 5 
None Ad-hoc  
 
(Unpredictable, poor 
control) 
Managed  
 
(Need for innovation 
identified, inconsistent 
outcomes) 
Defined  
 
(Innovation adoption 
procedures defined, 
consistent outputs) 
Quantitative  
 
(Innovation adoption process 
controlled and measured, integrated 
into organisation’s activities) 
Optimising  
 
(Emphasis on improving outputs 
of innovation adoption process; 
resources and activities 
synchronised) 
D
o
m
a
in
s 
Innovation  
 
(This could refer to process, 
product, organisational 
innovation, etc.) 
No innovation. 
Uncertain needs for 
innovation. 
Need for the innovation 
identified but no clear 
plan to achieve the 
adoption process. 
The need for the innovation 
is clear, the process to 
adopt the innovation into 
the organisation is defined. 
The need for the innovation is clear 
and the evidence behind the 
innovation is verifiable; the success of 
the innovation can be measured, and 
the innovation process is controlled. 
The innovation is compatible 
with the facility, has a clear 
advantage, and is of a high 
design quality. 
Users  
 
(Medical personnel, patients, 
healthcare organisation, 
research & development 
organisations, regulatory 
agencies)  
No users. 
One or two innovation role-
players with little to no 
influence at the facility, no 
management support. 
Innovation role-players 
(not their sole role) in 
the facility with some 
influence are identified. 
Limited management 
support and 
involvement. 
Innovation role-players 
identified, and have 
influence within the 
facility. There is 
management support, but 
their commitment and 
involvement is inconsistent. 
Innovation role-players have been 
identified in the facility, they have 
control over the innovation adoption 
process. There is management support 
and commitment, management is 
consistently involved and accepts a 
degree of accountability for the 
innovation adoption process. 
All employees are involved in the 
innovative adoption process. 
There is management support 
and commitment, management 
is consistently involved, 
supportive, and accepts 
accountability for the innovation 
adoption process. 
Organisational environment  
 
(Inner environment: goals, 
structure, culture, policies) 
Environment 
provides no room 
for innovation 
adoption process. 
Organisational structure 
prevents innovation 
adoption process from the 
beginning; there is no policy 
for innovation adoption; and 
culture is change resistant. 
The need for an 
innovation adoption 
process has been 
identified, but no 
standardised policy for 
adoption is followed. 
Structured innovation 
adoption procedures 
considered a standard 
business process; learning 
culture is practised 
inconsistently. 
Structured risk management and 
project management procedures, and 
implementation policies. Clear 
performance control. Culture is risk 
tolerant, learning is encouraged. 
Health facility’s goals and 
objectives are conducive to a 
culture of learning and 
improvement. Supportive 
environment. 
Information-acquiring  
 
(Outer environment & 
internal information 
network: information access, 
competitive pressures, 
external policies, customer 
needs and resources, 
communication network) 
No channels, no 
access to 
information. 
Information is difficult to 
access, or no effort is put 
into acquiring information. 
Organisation acquires 
information, but 
irregularly. 
Standard process for 
acquiring information from 
external communication 
channels and internal 
communication procedures. 
There is a greater ease of information 
access, the process of information 
acquiring does not only fall on one 
person; it is integrated into the 
organisation’s activities. Could be a 
result of policies and incentives. 
An emphasis on satisfying 
customers’ needs and involving 
internal and external customers 
drives the information-acquiring 
process. 
Costs  
 
(Financial aspects of the 
innovation adoption process) 
No finances. 
Inconsistent and non-
permanent sources of 
funding. 
Funding is consistent 
but not permanent. 
Consistent, permanent 
source of funding. 
Accountability for spending, (no 
spending unaccounted for). 
Spending is optimised. 
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Table 3: Innovation adoption process maturity capability for the innovation’s characteristics domain 
Innovation 
 
If the organisation is not looking at a 
specific innovation, skip this section 
and continue to ‘Users’ 
 
(The specific innovation looking to be 
implemented by the organisation: this 
could refer to process, product, 
organisational innovation, etc.) 
Maturity capability levels 
Level 0 Level 1 Level 2 Level 3 Level 4 Level 5 
None 
Ad-hoc  
 
(Unpredictable, poor 
control) 
Managed  
 
(Need for innovation 
identified, inconsistent 
outcomes) 
Defined  
 
(Innovation adoption 
procedures defined, 
consistent outputs) 
Quantitative  
 
(Innovation adoption process 
controlled and measured, 
integrated into organisation’s 
activities) 
Optimising  
 
(Emphasis on improving 
outputs of innovation 
adoption process; resources 
and activities synchronised) 
No 
innovation. 
Uncertain needs for 
innovation. 
Need for the innovation 
identified but no clear 
plan to achieve the 
adoption process[1]. 
The need for the 
innovation is clear; the 
process to adopt the 
innovation into the 
organisation is defined. 
The need for the innovation is 
clear and the evidence behind 
the innovation is verifiable, 
the success of the innovation 
can be measured, and the 
innovation process is 
controlled. 
The innovation is 
compatible with the 
facility, it has a clear 
advantage, and is of a high 
design quality. 
In
n
o
v
a
ti
o
n
 A
d
o
p
ti
o
n
 P
ro
c
e
ss
 [
2
] 
Search 
 
(Finding 
innovation 
opportunities; 
can be 
internal or 
external) 
Perceived 
advantage[3], 
evidence 
strength[4], 
design quality[5] 
No innovation 
present in 
the search 
phase. 
The evidence and design 
quality of the innovation 
leads the organisation to 
recognise a potential need 
for the innovation, but this 
need is not certain. The 
perceived advantage of the 
innovation varies drastically 
among stakeholders[6]. 
The evidence and design 
quality of the innovation 
leads the organisation to 
recognise the need for the 
innovation. The perceived 
advantage of the 
innovation varies 
considerably among 
stakeholders. 
The evidence and design 
quality of the innovation 
leads the organisation to 
recognise the need for the 
innovation. The perception 
about the innovation 
among stakeholders is that 
it is advantageous. 
The evidence strength and design 
quality of the innovation lead the 
organisation to recognise a clear 
need for the innovation. The 
evidence behind the innovation is 
verifiable, and the design of the 
innovation means its’ success or 
failure can be measured. 
The perceived advantage of the 
innovation among stakeholders 
is high. The innovation’s design 
quality is high. 
Select 
 
(Portfolio 
management; 
what 
innovations 
will be 
adopted) 
Compatibility[7], 
trial-ability[8], 
complexity[9] 
No innovation 
present in 
the select 
phase. 
Compatibility of the 
innovation with the 
organisation is poor; there 
is a high level of complexity 
that clouds the need for 
the innovation. 
There is a relative 
compatibility of the 
innovation with the 
organisation; however, the 
innovation is not trial-
able. The innovation’s 
complexity does not 
detract from the need for 
the innovation (although 
the complexity is high). 
The innovation is 
compatible with the 
organisation; however, it 
is necessary to make minor 
changes to the innovation 
before adoption. The level 
of complexity of the 
innovation does not 
detract from the need of 
the innovation. The 
innovation is trial-able. 
The innovation is compatible with 
the organisation. The level of 
complexity of the innovation does 
not detract from the clear need of 
the innovation. The innovation is 
trial-able allowing for the 
organisation to gauge what the 
success of the innovation will be. 
The innovation is completely 
compatible with the 
organisation. The complexity of 
the innovation does not take 
away from the clear advantage 
that the innovation provides 
the organisation. The 
innovation is trial-able. 
                                                     
1  This process includes the phases of innovation adoption: search, select, adoption, capture. 
2    A specific innovation cannot be in different phases of the innovation adoption process at the same time. It is assumed that in order to be adopted the innovation will sequentially go from Search to 
Select     to Adoption to Capture. 
3    Perceived advantage refers to the relative advantage that adopting this specific innovation will have for the organisation. 
4    Evidence strength refers to the evidence supporting the innovation, the strength is the extent to which the evidence is sound and convincing. 
5    Design quality refers to the quality of the actual innovation’s design, including how the innovation is presented. 
6    Stakeholders are interested parties’ who influence decisions but do not necessarily have a primary role in the adoption process, stakeholders in the innovation adoption process of a healthcare facility 
include: medical personnel, patients, the healthcare organisation, Research & Development organisations, and regulatory agencies. 
7    Compatibility refers to how well the innovation, that will potentially be adopted, fits into the organisation’s existing systems (the technical, physical and organisational systems). 
8    Trial-ability refers to how easily the innovation can be tested or prototyped at the organisation before being implemented. 
9    Complexity links to the compatibility of the innovation, it is the extent to which the innovation is challenging to use or understand. The complexity of the innovation is influenced by the time it will 
take to adopt the innovation, the steps required to adopt the innovation, the scope that the innovation covers, how radical and disruptive the innovation is, and how intricate the innovation is. 
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Innovation 
 
If the organisation is not looking at a 
specific innovation, skip this section 
and continue to ‘Users’ 
 
(The specific innovation looking to be 
implemented by the organisation: this 
could refer to process, product, 
organisational innovation, etc.) 
Maturity capability levels 
Level 0 Level 1 Level 2 Level 3 Level 4 Level 5 
None 
Ad-hoc  
 
(Unpredictable, poor 
control) 
Managed  
 
(Need for innovation 
identified, inconsistent 
outcomes) 
Defined  
 
(Innovation adoption 
procedures defined, 
consistent outputs) 
Quantitative  
 
(Innovation adoption process 
controlled and measured, 
integrated into organisation’s 
activities) 
Optimising  
 
(Emphasis on improving 
outputs of innovation 
adoption process; resources 
and activities synchronised) 
No 
innovation. 
Uncertain needs for 
innovation. 
Need for the innovation 
identified but no clear 
plan to achieve the 
adoption process[1]. 
The need for the 
innovation is clear; the 
process to adopt the 
innovation into the 
organisation is defined. 
The need for the innovation is 
clear and the evidence behind 
the innovation is verifiable, 
the success of the innovation 
can be measured, and the 
innovation process is 
controlled. 
The innovation is 
compatible with the 
facility, it has a clear 
advantage, and is of a high 
design quality. 
In
n
o
v
a
ti
o
n
 A
d
o
p
ti
o
n
 P
ro
c
e
ss
 [
2
] 
Adoption 
 
(Implementing 
the chosen 
innovation into 
the 
organisation) 
Adaptability[10] 
No innovation 
present in 
the adoption 
phase. 
The innovation is not able 
to adjust easily to meet the 
organisation’s needs: there 
is a high level of training 
required for adoption, as 
well as a high level of re-
engineering required. 
The innovation is able to 
adjust to meet the 
organisation’s needs; 
however, the re-
engineering required to 
accomplish this is 
complex. A moderate level 
of training is required for 
adoption. 
The innovation is able to 
adjust to meet the 
organisation’s needs 
through a straight forward 
re-engineering process; 
training is required for 
adoption. 
The innovation is able to adjust 
easily to meet the organisation’s 
needs; minimal training and re-
engineering required for adoption. 
The innovation meets the 
organisation’s needs without 
making adjustments. Little to 
no training and re-engineering 
are required for adoption. 
Capture 
 
(Process 
control and 
risk 
management, 
tracking the 
success of the 
innovation) 
Observability[11], 
verifiability[12] 
No innovation 
present in 
the capture 
phase. 
The innovation has poor 
observability; there is no 
clear way to measure the 
outcomes of the innovation. 
The proposed outcomes of 
the innovation are not 
verifiable as there is little 
to no quality evidence 
relating to the proposed 
outcome of adopting the 
innovation. 
The innovation’s outcomes 
are observable, although 
there is no defined way to 
measure the outcomes of 
the innovation. The 
proposed outcomes of the 
innovation are not 
verifiable; there is little 
quality evidence relating 
to the proposed outcomes 
of adopting the innovation. 
The outcomes of the 
innovation are observable; 
there is a defined way to 
measure the outcomes of 
the innovation. The 
proposed outcomes of the 
innovation are not 
verifiable; there is little 
strong quality evidence 
relating to the proposed 
outcomes of adopting the 
innovation. 
The outcomes of the innovation 
are observable; there is a clear 
way to measure the outcomes of 
the innovation. The proposed 
outcomes of the innovation are 
verifiable by quality evidence 
relating to the proposed outcomes 
of adopting the innovation. 
The innovation's observability is 
excellent; there is a clear way 
to measure the outcomes of the 
innovation. The proposed 
outcomes of the innovation are 
verifiable due to the strong and 
high-quality evidence relating 
to the proposed outcome 
adopting the innovation. 
  
                                                     
1    This process includes the phases of innovation adoption: search, select, adoption, capture. 
2    A specific innovation cannot be in different phases of the innovation adoption process at the same time. It is assumed that in order to be adopted the innovation will sequentially go from Search to 
Select     to Adoption to Capture. 
3    Perceived advantage refers to the relative advantage that adopting this specific innovation will have for the organisation. 
10    Adaptability refers to how easily the innovation is able to adjust to the organisation. This includes how much training is required for innovation adoption and integration into business and organisational 
processes, what level of re-engineering of the innovation is required, and how well the innovation can be adapted to meet the organisation’s needs. 
11    Observability refers to how easily the adopted innovations’ outcomes can be observed and measured by the organisation. 
12    Verifiability refers to the evidence strength and quality relating to the proposed outcome of adopting the innovation. 
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Table 4: Innovation adoption process maturity capability for the users’ domain 
Users 
 
(Medical personnel, patients, healthcare 
organisation, R&D organisations, 
regulatory agencies) 
Maturity capability levels 
Level 0 Level 1 Level 2 Level 3 Level 4 Level 5 
None 
Ad-hoc  
 
(Unpredictable, 
poor control) 
Managed  
 
(Need for innovation 
identified, 
inconsistent 
outcomes) 
Defined  
 
(Innovation adoption 
procedures defined, 
consistent outputs) 
Quantitative  
 
(Innovation adoption process 
controlled and measured, 
integrated into organisation’s 
activities) 
Optimising  
 
(Emphasis on improving outputs of 
innovation adoption process; 
resources and activities 
synchronised) 
No users. 
One or two 
innovation role-
players7 with 
little to no 
influence at the 
facility, no 
management 
support8. 
Innovation role-
players (not their 
sole role) in 
facility with some 
influence are 
identified. Limited 
management 
support and 
involvement. 
Innovation role-players 
identified, and have 
influence within the 
facility. There is 
management support, 
but their commitment 
and involvement is 
inconsistent. 
Innovation role players have 
been identified in the facility, 
they have control over the 
innovation adoption process. 
There is management support 
and commitment, management is 
consistently involved and 
accepts a degree of 
accountability for the 
innovation adoption process. 
All employees are involved in the 
innovation adoption process. 
There is management support and 
commitment, management is 
consistently involved, supportive, 
and accepts accountability for the 
innovation adoption process. 
In
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Search 
 
(Finding 
innovation 
opportunities; 
can be internal 
or external) 
Networker9 
No users in 
the search 
phase. 
There is an 
individual(s) who 
performs the tasks of 
a networker within 
the organisation; 
however, this is not 
their formal role and 
they have little to no 
influence. No 
management 
support. 
There is an 
individual(s) who 
performs the tasks of 
a networker within 
the organisation; 
however, this is not 
their formal role, and 
they have some 
influence in the 
organisation. Limited 
management support 
and involvement. 
There is an individual(s) 
who performs the tasks of 
a networker within the 
organisation; this is 
included in their formal 
role, and they have 
influence in the 
organisation. There is 
management support, but 
their commitment and 
involvement is 
inconsistent. 
There is an individual(s) who 
performs the tasks of a networker 
within the organisation; this is 
included in their formal role, and 
they have influence in the 
organisation and are respected. The 
individual(s) has responsibilities and 
actively participates in the 
innovation adoption process. There is 
management support and 
commitment; management is 
consistently involved and accepts a 
degree of accountability for the 
innovation adoption process. 
There is an individual(s) who formally 
performs the tasks of a networker 
within the organisation, but all 
employees are encouraged and involved 
in contributing to the responsibilities 
that the networker has. Employees 
actively participate in the innovation 
adoption process. There is management 
support and commitment; management 
is consistently involved, supportive, 
and accepts accountability for the 
innovation adoption process. 
                                                     
7  Stakeholders are different from role-players; role-players will have a hands-on position during the adoption process, whereas stakeholders are interested parties who influence decisions but do not 
necessarily have a primary role in the adoption process. A stakeholder can be a role-player. 
8  The extent of the organisation’s managerial support, patience, commitment, involvement, and accountability during the innovation adoption process can contribute towards the success or failure of 
an innovation adoption process. Managers have significant influence over the decision to adopt an innovation, even though they are often not the intended users. 
9  The networker studies trends within technology, society, markets, and regulations to recognise opportunities. The networker will also interact with people within the organisation to recognise the 
internal needs and opportunities. The networker is responsible for creating connections with external organisations, or with individuals who have corresponding objectives. 
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Select 
 
(Portfolio 
management; 
what 
innovations will 
be adopted) 
Co-ordinator10, 
anthropologist11, 
product 
champion12 
No users in 
the select 
phase. 
There are individuals 
who perform the task 
of co-ordinator, 
anthropologist, and 
product champion 
within the 
organisation; 
however, this is not 
their formal role and 
they have little to no 
influence. No 
management 
support. 
There are individuals 
who perform the task 
of a co-ordinator, 
anthropologist, and 
product champion 
within the 
organisation; 
however, this is not 
their formal role, 
though they have 
some influence in the 
organisation. Limited 
management support 
and involvement. 
There are individuals who 
perform the task of a co-
ordinator, anthropologist, 
and product champion 
within the organisation; 
this is included in their 
formal role, and they have 
influence in the 
organisation. There is 
management support, but 
their commitment and 
involvement is 
inconsistent. 
There are individuals who perform 
the task of a co-ordinator, 
anthropologist, and product 
champion within the organisation; 
this is included in their formal role, 
and they have influence in the 
organisation and are respected. The 
individuals have responsibilities and 
actively participate in the innovation 
adoption process. There is 
management support and 
commitment; management is 
consistently involved and accepts a 
degree of accountability for the 
innovation adoption process. 
There are individuals who formally 
perform the task of a co-ordinator, 
anthropologist, and product champion 
within the organisation, but all 
employees are encouraged and involved 
in contributing to the responsibilities 
that the co-ordinator, anthropologist, 
and product champion has. Employees 
actively participate in the innovation 
adoption process. There is management 
support and commitment. Management 
is consistently involved, supportive, 
and accepts accountability for the 
innovation adoption process. 
Adoption 
 
 
(Implementing 
the chosen 
innovation into 
the 
organisation) 
Co-ordinator, 
builder13, 
anthropologist, 
product 
champion 
No users in 
the 
adoption 
phase. 
There are individuals 
who perform the task 
of a co-ordinator, 
builder, 
anthropologist, and 
product champion 
within the 
organisation; 
however, this is not 
their formal role and 
they have little to no 
influence. No 
management 
support. 
There are individuals 
who perform the task 
of a co-ordinator, 
builder, 
anthropologist, and 
product champion 
within the 
organisation; 
however, this is not 
their formal role. 
They have some 
influence in the 
organisation. Limited 
management support 
and involvement. 
There are individuals who 
perform the task of a co-
ordinator, builder, 
anthropologist, and 
product champion within 
the organisation. This is 
included in their formal 
role, and they have 
influence in the 
organisation. There is 
management support, but 
their commitment and 
involvement is 
inconsistent. 
There are individuals who perform 
the task of a co-ordinator, builder, 
anthropologist, and product 
champion within the organisation. 
This is included in their formal role, 
and they have influence in the 
organisation and are respected. The 
individuals have responsibilities and 
actively participate in the innovation 
adoption process. There is 
management support and 
commitment, and management is 
consistently involved and accepts a 
degree of accountability for the 
innovation adoption process. 
There are individuals who formally 
perform the task of a co-ordinator, 
builder, anthropologist, and product 
champion within the organisation, but 
all employees are encouraged and 
involved in contributing to the 
responsibilities that the co-ordinator, 
builder, anthropologist, and product 
champion have. Employees actively 
participate in the innovation adoption 
process. There is management support 
and commitment, and management is 
consistently involved, supportive, and 
accepts accountability for the 
innovation adoption process. 
Capture 
 
(Process control 
and risk 
management; 
tracking the 
success of the 
innovation) 
Co-ordinator, 
product 
champion 
No users in 
the capture 
phase. 
There are individuals 
who perform the task 
of co-ordinator and 
product champion 
within the 
organisation; 
however, this is not 
their formal role and 
they have little to no 
influence. No 
management 
support. 
There are individuals 
who perform the task 
of co-ordinator and 
product champion 
within the 
organisation; 
however, this is not 
their formal role. 
They have some 
influence in the 
organisation. Limited 
management support 
and involvement. 
There are individuals who 
perform the task of co-
ordinator and product 
champion within the 
organisation. This is 
included in their formal 
role, and they have 
influence in the 
organisation. There is 
management support, but 
their commitment and 
involvement is 
inconsistent. 
There are individuals who perform 
the task of co-ordinator and product 
champion within the organisation. 
This is included in their formal role, 
and they have influence in the 
organisation and are respected. The 
individuals have responsibilities and 
actively participate in the innovation 
adoption process. There is 
management support and 
commitment, and management is 
consistently involved and accepts a 
degree of accountability for the 
innovation adoption process. 
There are individuals who formally 
perform the task of co-ordinator and 
product champion within the 
organisation, but all employees are 
encouraged and involved in 
contributing to the responsibilities that 
the co-ordinator and product champion 
have. Employees actively participate in 
the innovation adoption process. There 
is management support and 
commitment, and management is 
consistently involved, supportive, and 
accepts accountability for the 
innovation adoption process. 
 
                                                     
10  The co-ordinator ensures that the projects’ resources, objectives, and risks are balanced, and will promote concepts and opportunities. The co-ordinator must schedule, prioritise, and guarantee 
project completion through overcoming obstacles faced. 
11  he anthropologist must have an understanding of people’s interactions (both emotional and physical) with services, products, their environment, and with other people. The anthropologist can 
anticipate stakeholders’ needs and is able to influence people’s attitudes and behaviours. 
12  The product champion ensures that the organisation’s activities are aligned with their objectives and strategies. They will prioritise opportunities to implement and will monitor a project’s metrics. 
This person is committed to the implementation of the innovation and is able to push the project through the internal barriers. 
13  The builder creates, demonstrates, and defines tangible concepts; the builder will ensure the product or service is ready to be supplied to the customer. 
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Table 5: Innovation adoption process maturity capability for the organisational environment domain 
Organisational environment 
 
(Inner environment: goals, structure, 
culture, policies) 
Maturity capability levels 
Level 0 Level 1 Level 2 Level 3 Level 4 Level 5 
None 
Ad-hoc  
 
(Unpredictable, poor 
control) 
Managed  
 
(Need for innovation 
identified; inconsistent 
outcomes) 
Defined  
 
(Innovation adoption 
procedures defined; 
consistent outputs) 
Quantitative  
 
(Innovation adoption 
process controlled and 
measured; integrated into 
organisation’s activities) 
Optimising  
 
(Emphasis on improving outputs 
of innovation adoption process; 
resources and activities 
synchronised) 
Environment 
provides no 
room for 
innovation 
adoption 
process. 
Organisational 
structure prevents 
innovation adoption 
process from the 
beginning; there is no 
policy for innovation 
adoption, and culture 
is change resistant14. 
The need for an 
innovation adoption 
process has been 
identified, but no 
standardised policy for 
adoption is followed. 
Structured innovation 
adoption procedures 
are considered a 
standard business 
process; learning 
culture is practised 
inconsistently. 
Structured risk 
management 
procedures, project 
management 
procedures, and 
implementation 
policies. Clear 
performance control. 
Culture is risk tolerant; 
learning is encouraged. 
Health facility’s goals and 
objectives are conducive to a 
culture of learning and 
improvement. Supportive 
environment. 
In
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Search  
 
(Finding 
innovation 
opportunities; 
can be 
internal or 
external) 
Organisation 
communication 
procedures15, 
culture16, learning 
climate17 
The 
organisational 
environment is 
not conducive 
to searching for 
innovations to 
adopt. 
The organisation’s 
communication 
procedures are poorly 
controlled; there is a 
change resistant culture 
within the organisation. 
The climate within the 
organisation is risk 
averse and does not 
promote learning. 
The organisation’s 
communication procedures 
are controlled but the 
procedures are not 
standardised. There is a 
change resistant culture 
within the organisation. The 
climate within the 
organisation is risk averse; 
however, there is a culture 
of learning that is 
inconsistently promoted. 
The organisation’s 
communication 
procedures are controlled 
and standardised. An 
organisational culture of 
learning is practiced. 
There is a level of 
tolerance towards risk. 
The organisation’s 
communication procedures 
are well controlled. The 
organisational culture is risk 
tolerant; learning is 
encouraged. 
The organisation’s communication 
procedures are excellently 
controlled. The organisational 
culture is tolerant to change, and 
the climate within the 
organisation is supportive and 
promotes learning. 
                                                     
14  Change resistant: Behavioural barriers within an organisation consist of decision–makers’ motivations, priorities, rationality, and inclination towards risk and change. 
15  Communication procedures refer to the organisation’s established external and internal communication policies that are enforced and followed throughout the organisation. 
16  Organisational culture affects the ease and success of the innovation adoption process. The level of collaboration influences the organisation’s culture, and integration between departments and 
personnel, by how tolerant to risk the organisation is, and whether a climate of learning is encouraged. The behaviours of the users in the organisation also influence the organisational culture. 
Behaviours include preconceived beliefs about the innovation, resistance to change, and the attitude towards risk. 
17  An organisation that is learning orientated means that research and development within the company, knowledge retention, and support for skill development is encouraged. 
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Select 
 
(Portfolio 
management; 
what 
innovations 
will be 
adopted) 
Decision-making 
procedure18; 
influenced by 
organisational 
structure19 and 
goals and 
objectives20 
The 
organisational 
environment is 
not conducive 
to selecting 
innovations. 
Decision-making 
procedures are poorly 
controlled and structural 
aspects of the 
organisation prevent an 
innovation from being 
selected. The goals and 
objectives of the 
organisation are not 
communicated clearly, 
and do not encourage 
innovation. 
Decision-making procedures 
are poorly controlled. The 
organisational structure does 
not prevent an innovation 
from being selected, 
although it potentially 
creates further obstacles to 
selecting an innovation. The 
goals and objectives of the 
organisation are not 
communicated clearly, 
although they do encourage 
innovation adoptions. 
Decision-making 
procedures are controlled. 
The organisational 
structure does not impede 
the selection of an 
innovation. The goals and 
objectives of the 
organisation are 
communicated and 
encourage innovation 
adoptions. 
Decision-making procedures 
are well controlled. The 
organisational structure 
does not impede the 
selection of an innovation. 
The goals and objectives of 
the organisation are clearly 
communicated, and 
stimulate innovation 
adoptions. 
Decision-making procedures are 
controlled effectively and the 
organisational structure is not a 
barrier to selecting an innovation 
for adoption. The goals and 
objectives of the organisation are 
communicated clearly and 
understood by all employees in 
the organisation. The goals and 
objectives of the organisation 
include innovation and encourage 
the innovation adoption process 
to thrive. 
Adoption 
 
(Implementing 
the chosen 
innovation 
into the 
organisation) 
Implementation 
policies21; change 
management22 
The 
organisational 
environment is 
not conducive 
to adopting 
innovations. 
Implementation is poorly 
controlled. There is no 
change management 
procedure. 
Implementation is controlled 
but there are no formal 
implementation polices. The 
need for change management 
is recognised; the change 
management procedure is 
sporadically practised and 
not formalised. 
Implementation is 
controlled, and there are 
formal implementation 
polices. The change 
management procedure is 
formalised; however, it is 
still sporadically 
practiced. 
Implementation is 
controlled; there are 
formal, structured 
implementation polices. 
The change management 
procedure is formalised and 
is practised regularly. 
Implementation is excellently 
controlled; there are formalised 
implementation polices. Change 
management is a formal policy 
that is continuously practised and 
controlled. 
Capture 
 
(Process 
control and 
risk 
management; 
tracking the 
success of the 
innovation) 
Quality control23 
and risk 
management24 
The 
organisational 
environment is 
not conducive 
to capturing 
innovations. 
Quality assessments are 
poorly controlled and 
sporadically carried out. 
There is no formal risk 
management procedure 
in the organisation. 
Quality assessments are 
controlled but there are no 
formal quality management 
procedures. The need for risk 
management is recognised; 
risk management is 
sporadically practised and 
not formalised. 
Quality assessments are 
controlled, there are 
formal quality 
management policies. The 
risk management 
procedure is formalised; 
however, it is still 
sporadically practiced. 
Quality assessments are 
controlled; there are 
formal, structured quality 
management policies. The 
risk management procedure 
is formalised and is 
practised on a regular basis. 
Quality assessments are 
excellently controlled; there are 
formalised quality management 
policies. Risk management is a 
formal policy that is continuously 
practised and controlled. 
 
  
                                                     
18  An organisation must have a structured, established decision-making process and effective management of this decision-making procedure. 
19  Organisation structure includes the age, size, and architecture of the organisation (the organisation’s architecture could be a flat organisational structure, a hierarchical organisation, or something in 
between the two). The organisation includes the healthcare facility and the government Department of Health. 
20  Goals and objectives: are these goals clearly communicated, and are they conducive to a positive innovation adoption environment within the healthcare organisation? 
21  Implementation policy is the course of action by which the organisation abides when implementing a new process, product, etc. The quality of an organisation’s implementation policies can be an 
indication of the success or failure to adopt an innovation. 
22  Behavioural barriers within an organisation consist of decision–makers’ motivations, priorities, rationality, and inclination towards risk and change; for this reason, change management is required to 
control the change process, and to minimise resistance as far as possible. 
23  Quality control policies will minimise the potential risks of adopting a new innovation, meaning that there will be a higher chance of innovation adoption success. 
24  Risk management is required to predict and evaluate potential risks, and to put procedures in place that control and mitigate the identified risks as far as possible. 
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Table 6: Innovation adoption process maturity capability for the information acquisition domain 
Information-acquiring 
 
(Outer environment and internal 
information network: information 
access, competitive pressures, external 
policies, customer needs and resources, 
communication network) 
Maturity capability levels 
Level 0 Level 1 Level 2 Level 3 Level 4 Level 5 
None 
Ad-hoc  
 
(Unpredictable, 
poor control) 
Managed  
 
(Need for innovation 
identified; inconsistent 
outcomes) 
Defined  
 
(Innovation adoption 
procedures defined; 
consistent outputs) 
Quantitative  
 
(Innovation adoption process 
controlled and measured; 
integrated into organisation’s 
activities) 
Optimising  
 
(Emphasis on improving outputs 
of innovation adoption process; 
resources and activities 
synchronised) 
No channels, 
no access to 
information. 
Information is 
difficult to 
access, or no 
effort is put into 
acquiring 
information. 
Organisation acquires 
information, but 
irregularly. 
Standard process for 
acquiring information 
from external 
communication channels 
and internal 
communication 
procedures. 
There is a greater ease of 
information access, the 
process of information 
acquiring does not only fall on 
one person; it is integrated 
into the organisation’s 
activities. Could be a result of 
policies and incentives. 
An emphasis on satisfying 
customers’ needs; involving 
internal and external 
customers  
drives the information 
acquiring  
process. 
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Search  
 
(Finding 
innovation 
opportunities; 
can be internal 
or external) 
External and 
internal 
communication 
channels; ease of 
information 
access25 
No 
communication 
channels in 
place. 
Information is 
difficult to access; 
communication 
channels (internal 
and external) 
exist, but no effort 
is put into 
acquiring 
information from 
these channels. 
Information is accessible 
through the 
communication channels 
(internal and external) 
that exist. Effort is put 
into acquiring information 
from these channels; 
information acquisition is 
sporadic. 
Information is accessible 
through the communication 
channels that exist. There is 
a standardised procedure that 
is followed for acquiring 
information from these 
channels. It is easy to access 
information. 
Information is easily accessible 
through the communication 
channels that exist. There is a 
standardised procedure that is 
followed for acquiring information 
from these channels; information 
is consistently obtained and is 
integrated into the organisation’s 
activities. 
Information is easily accessible 
through the communication 
channels that exist; 
the organisation is continuously 
looking to establish new 
communication channels. 
Customers (internal and external) 
are considered and involved when 
searching for innovative 
opportunities. 
Select 
 
(Portfolio 
management; 
what 
innovations 
will be 
adopted) 
Benchmarking 
pressures26, 
external policies 
and incentives27, 
customers’ needs 
and resources28 
No pressures or 
resources to 
select an 
innovation. 
Competitive 
pressures have no 
effect on 
innovation 
selection. No 
external policies or 
incentives in place 
that pressure the 
organisation to 
select an 
innovation. 
Customers’ needs 
are not known or 
considered. 
Innovations are 
selected randomly. 
Competitive pressures lead 
to the organisation 
irregularly selecting 
innovations to adopt. Some 
external policies or 
incentives are in place that 
pressure the organisation 
to select an innovation. 
Customers’ needs are 
known but are not 
consciously considered. 
Innovation selection is 
managed. 
Competitive pressures lead to 
the organisation acquiring 
and selecting what 
information to pursue 
further. External policies or 
incentives are in place that 
pressure the organisation to 
select an innovation. 
Customers’ needs are known 
and are consciously 
considered during selection. 
Innovation selection is 
managed, and the selections 
of innovations has a 
consistent output. 
Competitive pressures lead to the 
organisation selecting innovations 
to adopt faster. External policies 
or incentives are in place that 
pressure the organisation to select 
an innovation. Customers’ needs 
are known, and are consciously 
considered and given a higher 
weighting during selection. 
Innovation selection is integrated 
into the organisation’s activities. 
The selection procedure 
emphasises satisfying customers’ 
needs. External policies or 
incentives 
are in place that pressure the 
organisation to select an 
innovation. 
                                                     
25  The ease of information access influences the rate of the innovation adoption process, the decision of whether to adopt the innovation, and whether the organisation receives information about 
available innovations to address current challenges faced by the organisation. 
26  Benchmarking pressure is a result of a competing organisation or well-respected organisation adopting a particular innovation compelling the organisation being considered to do the same. 
27  External policies and incentives could be policies or incentives from the government or from international organisations. Public opinion could be a contributing incentive to adopt an innovation; 
incentives could be monetary. 
28  Knowing the customers’ needs (includes internal and external customers) can influence what innovations will be selected for adoption. Involving customers in the innovation adoption process will 
mean that the process is more likely to succeed in meeting the customers’ needs. 
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Adoption 
 
(Implementing 
the chosen 
innovation into 
the 
organisation) 
Innovation 
adoption 
management 
policies; project 
management29, 
communication 
network30 
No 
communication 
channels in 
place; 
innovation 
adoption 
management is 
non-existent. 
The organisation’s 
internal 
communication 
network is not 
effective, making 
information 
difficult to access. 
Project 
management 
policies exist but 
are poorly 
controlled. 
The organisation’s internal 
communication network is 
effective for transmitting 
information about the 
adoption process. Project 
management policies exist 
and are managed; 
however, the outcomes are 
inconsistent. 
The organisation’s internal 
communication network is 
effective for transmitting 
information about the 
adoption process; the internal 
communication network has 
been standardised. Project 
management policies exist 
and are managed; the 
outcomes of adoption are 
consistent. 
The organisation’s internal 
communication network is 
effective for transmitting 
information about the adoption 
process; the internal 
communication network has been 
integrated into the organisation’s 
activities. Project management 
policies are managed; the 
outcomes are consistent and 
measurable. 
The organisation’s internal 
communication 
network is optimised and provides 
a channel for internal customers 
to offer input during the adoption 
stage of the process. There is 
greater ease of involving 
customers 
in the adoption stage of the 
process. 
Project management policies exist 
and 
are optimally managed. 
Capture 
 
(Process 
control and 
risk 
management; 
tracking the 
success of the 
innovation) 
Communication 
network: 
feedback 
systems, quality 
management31 
No 
communication 
channels in 
place to capture 
information 
from the 
innovation. 
The organisation’s 
internal 
communication 
network is not 
effective; feedback 
on the adopted 
innovation is 
difficult to access. 
Quality 
management 
policies are not 
communicated to 
the appropriate 
personnel. This 
leads to poor 
process control. 
The organisation’s internal 
communication network 
provides feedback about 
the adopted innovation; 
however, this happens 
irregularly and is difficult 
to access. Quality 
management policies are 
communicated to the 
appropriate personnel; the 
policies produce 
inconsistent outcomes. 
The organisation’s internal 
communication network is 
effective, feedback is a 
standard practice within the 
organisation. Quality 
management policies are 
communicated and practised 
by the appropriate personnel. 
The organisation’s internal 
communication network is 
effective; feedback on the 
adopted innovation is easy to 
access. Quality management 
policies are well communicated 
and practiced; the quality of the 
adopted innovation is measurable. 
The organisation’s internal 
communication network 
effectively 
provides feedback on the status of 
the adopted 
innovation, allowing for optimal 
control over the implemented 
innovation. Quality management 
policies are known and practised 
by all personnel. 
 
  
                                                     
29  Project management includes managing the planning, initiating, and controlling procedures during the adoption phase. Project managers need to ensure that the innovation is adopted within an 
allocated time frame while realising the objectives of the innovation.   
30  Communication network refers to the organisation’s external and internal communication channels, and how well the organisation is networked with external organisations.  
31  Quality management will minimise the potential risks of adopting a new innovation, meaning that there will be a higher chance of innovation adoption success. 
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Table 7: Innovation adoption process maturity capability for the costs domain 
Costs 
 
(Financial aspects of the innovation 
adoption process) 
Maturity capability levels 
Level 0 Level 1 Level 2 Level 3 Level 4 Level 5 
None 
Ad-hoc  
 
(Unpredictable, poor 
control) 
Managed  
 
(Need for innovation 
identified, inconsistent 
outcomes) 
Defined  
 
(Innovation adoption 
procedures defined, 
consistent outputs) 
Quantitative  
 
(Innovation adoption 
process controlled and 
measured, integrated 
into organisation’s 
activities) 
Optimising  
 
(Emphasis on improving 
outputs of innovation 
adoption process, 
resources and activities 
synchronised) 
No finances. 
Inconsistent and non-
permanent sources of 
funding32. 
Funding is consistent 
but not permanent. 
Consistent, permanent 
source of funding. 
Accountability33 for 
spending, (no spending 
unaccounted for). 
Spending is optimised34. 
In
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Search 
 
(Finding 
innovation 
opportunities, 
can be 
internal or 
external)  
Research & 
development 
budget35 
No budget. 
Research & development 
budget is present within 
the organisation, 
however the source and 
amount allocated to this 
budget is inconsistent. 
Research & development 
budget is consistent, 
however the funding is not 
permanent. 
Research & development 
budget is consistent and 
permanent. 
There is personal 
accountability for 
everything spent from the 
research and development 
budget, no spending is 
unaccounted for. 
The spending in the research 
& development budget is 
optimised to receive the best 
results of searching for 
innovations. 
Select 
 
(Portfolio 
management, 
what 
innovations 
will be 
adopted) 
Acquisition 
costs36, financial 
incentives37, 
financial 
resources38, 
opportunity 
costs39 
No finances. 
Inconsistent sources of 
funding for acquisition of 
innovations, little to no 
financial resources 
allocated to the 
selection phase, no 
financial incentives to 
select an innovation. 
Acquisition costs 
overshadow the benefits 
of adoption. 
The budget available for 
the acquisition costs is 
consistent, however the 
funding is not permanent. 
Some financial resources 
are allocated to the 
selection phase, no 
financial incentives to 
select an innovation. The 
costs of acquisition 
overshadow the benefits of 
adoption. 
The budget available for the 
acquisition costs is consistent 
and permanent. Financial 
resources are allocated to 
the selection phase, there 
are financial incentives to 
select an innovation. 
Opportunity benefits are 
considered with the same 
weighting as the costs of 
acquisition. 
There is personal 
accountability for 
everything spent from the 
finances allocated to 
acquisition, no spending is 
unaccounted for. Financial 
resources are appropriately 
allocated to the selection 
phase, there are financial 
incentives to select an 
innovation to be adopted. 
The budget available for the 
acquisition costs is consistent 
and permanent. Financial 
resources are optimally 
allocated to the selection 
phase to ensure maximum 
benefits from these 
resources. There are 
financial incentives to select 
an innovation to be adopted. 
                                                     
32  Funding consistency: financial resources available for the innovation may not be consistent, which will affect the innovation adoption process. 
33  ‘Accountability’ refers to the organisation’s ability to account for the finances spent on the innovation. Thus, the organisation’s ability to report on the spending of the financial resources in relation 
to the adoption of an innovation or the impact of the adoption of such an innovation. 
34  ‘Optimised spending’ refers to ensuring that spending is as effective as possible, getting the most value for the money spent.  
35  ‘Research and development budget’ relates to the success that the company will have during the search phase of the innovation adoption process. The greater the research and development budget is 
the higher the chances are that the organisation will find an innovation that is compatible and meets their needs. A limited budget in this phase would mean limited information access. 
36  ‘Acquisition costs’ relates to how much money the organisation will need to spend to attain the innovation (this is closely related to the research and development budget). 
37  ‘Financial incentives’ is an incentive provided as money in order to adopt an innovation.  
38  Financial resources will not necessarily come from the organisation’s budget, the financial resources could be funded by the government, by an NGO, by an international governing body etc.  
39  ‘Opportunity costs’ are those costs benefits which would be missed out on if the company failed to adopt an innovation. 
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Adoption 
 
(Implementing 
the chosen 
innovation 
into the 
organisation) 
Adoption costs40 No finances. 
Inconsistent sources of 
funding for adoption of 
an innovation. 
Consistent sources of 
funding for adoption of an 
innovation, however 
funding is not permanent. 
Consistent and permanent 
sources of funding for 
adoption of an innovation. 
There is personal 
accountability for 
everything spent from the 
finances allocated to 
adoption, no spending is 
unaccounted for. 
The budget available for the 
adoption costs is consistent 
and permanent. Financial 
resources are optimally 
allocated to the adoption 
phase to ensure maximum 
benefits from the 
opportunity are realised. 
Capture 
 
(Process 
control and 
risk 
management, 
tracking the 
success of the 
innovation) 
Operational41 and 
maintenance 
costs42 
No finances. 
Inconsistent sources of 
funding for operational 
costs of innovations. 
Little to no financial 
resources allocated to 
the maintenance of the 
innovation. 
Consistent sources of 
funding for operation and 
maintenance of an 
innovation, however 
funding is not permanent. 
Consistent and permanent 
sources of funding for 
operation and maintenance 
of an innovation. 
There is personal 
accountability for 
everything spent from the 
finances allocated to 
operation and maintenance 
of the innovation, no 
spending is unaccounted 
for. 
The budget available for the 
operation and maintenance 
costs is consistent and 
permanent. Financial 
resources are optimally 
allocated to the capture 
phase to ensure maximum 
benefits from the 
opportunity are realised. 
 
                                                     
40  ‘Adoption costs’ include the initial investment required to adopt the innovation versus the opportunity costs of the innovation (benefits). 
41  ‘Operational costs’ are the finances required once the innovation has been adopted into the organisation to operate the innovation. 
42  ‘Maintenance costs’ are the finances required once the innovation has been adopted into the organisation to maintain the innovation. 
